• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Biologic pathways for chronic spontaneous urticaria and their regulation by benralizumab.

作者信息

Ghosh Debajyoti, Karim Rashid, Zhang Xiang, Singh Umesh, Bernstein Jonathan A

机构信息

Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Department of Electrical Engineering and Computer Science, University of Cincinnati College of Engineering and Applied Science, Cincinnati, Ohio, USA.

出版信息

Allergy. 2022 Dec;77(12):3687-3689. doi: 10.1111/all.15493. Epub 2022 Sep 8.

DOI:10.1111/all.15493
PMID:36004497
Abstract
摘要

相似文献

1
Biologic pathways for chronic spontaneous urticaria and their regulation by benralizumab.慢性自发性荨麻疹的生物学途径及其受贝那利珠单抗的调节
Allergy. 2022 Dec;77(12):3687-3689. doi: 10.1111/all.15493. Epub 2022 Sep 8.
2
Treatment of chronic spontaneous urticaria with benralizumab: Report of primary endpoint per-protocol analysis and exploratory endpoints.使用贝那利珠单抗治疗慢性自发性荨麻疹：主要终点符合方案分析及探索性终点报告
Allergy. 2021 Apr;76(4):1277-1280. doi: 10.1111/all.14713. Epub 2020 Dec 28.
3
A case of chronic spontaneous urticaria unresponsive to ligelizumab successfully treated with omalizumab.一例对利吉珠单抗无反应的慢性自发性荨麻疹经奥马珠单抗成功治疗的病例。
Dermatol Ther. 2022 Nov;35(11):e15859. doi: 10.1111/dth.15859. Epub 2022 Oct 4.
4
Combined treatment with omalizumab and secukinumab in a patient with chronic spontaneous urticaria and psoriasis.奥马珠单抗和司库奇尤单抗联合治疗一名慢性自发性荨麻疹和银屑病患者。
Dermatol Ther. 2022 Sep;35(9):e15638. doi: 10.1111/dth.15638. Epub 2022 Jul 15.
5
Benralizumab for Chronic Spontaneous Urticaria.贝那利珠单抗治疗慢性自发性荨麻疹
N Engl J Med. 2020 Oct 1;383(14):1389-1391. doi: 10.1056/NEJMc2016395.
6
Ligelizumab for chronic spontaneous urticaria.利吉珠单抗治疗慢性自发性荨麻疹。
Br J Dermatol. 2020 Nov;183(5):829-830. doi: 10.1111/bjd.18901. Epub 2020 Mar 5.
7
Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis.在一名患有慢性自发性荨麻疹和特应性皮炎的47岁女性中同时使用奥马珠单抗和度普利尤单抗。
Int J Dermatol. 2022 May;61(5):e173-e174. doi: 10.1111/ijd.16009. Epub 2021 Nov 23.
8
Benefit of benralizumab treatment in a patient with chronic symptomatic dermographism.贝那利珠单抗治疗慢性症状性皮肤划痕症患者的疗效
J Eur Acad Dermatol Venereol. 2019 Nov;33(11):e413-e415. doi: 10.1111/jdv.15720. Epub 2019 Jun 18.
9
Dupilumab: a new frontier for chronic urticaria. A case series and review of the literature.度普利尤单抗：慢性荨麻疹的新突破。病例系列及文献综述。
Int J Dermatol. 2024 Mar;63(3):399-401. doi: 10.1111/ijd.17016. Epub 2024 Jan 10.
10
How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab.嗜酸性粒细胞与慢性自发性荨麻疹有多大关联？使用贝那利珠单抗减少嗜酸性粒细胞数量并无临床获益的证据。
Br J Dermatol. 2024 Jul 16;191(2):153-154. doi: 10.1093/bjd/ljae165.

引用本文的文献

1
A powerful tool with a narrow focus: Aiming genome-wide association studies at chronic spontaneous urticaria.一种聚焦狭窄的强大工具：针对慢性自发性荨麻疹开展全基因组关联研究。
J Allergy Clin Immunol. 2023 May;151(5):1249-1251. doi: 10.1016/j.jaci.2023.03.009. Epub 2023 Mar 21.